Table 2 Measurement points
Assessment/Questionnaire | Baseline (T0) | 2Â weeks after intake (T1) | 2Â months after intake (T2) |
|---|---|---|---|
Primary Outcome Parameter | |||
 Decisional Conflict |  |  |  |
  Decisional Conflict Scale patient |  | X | X |
  VAS patient (additional) |  | X | X |
  VAS clinician (additional) |  | X |  |
Secondary Outcome Parameters | |||
 Patient participation in mental health (treatment).   Patient Participation Questionnaire |  | X | X |
 Shared Decision Making process   SDM-Q-9 Patient and clinician. |  | X | X |
 Working alliance   PDRQ-9 |  | X | X |
 Adherence to treatment   Drop-out, no-show |  | EPR | EPR |
 Symptoms-functioning   SQ-48 (=ROM) | X | X | X |
Patients’ characteristics | |||
 Patients’ characteristics   (sex, age, educational level, diagnosis, SQ-48 score, previous treatment at GGz Breburg, length of waiting) | EPD |  |  |
 Motivation   Demand for treatment on their own initiative? (1 item) | X |  |  |
 Achieving personal treatment goals   (1 item) |  |  | X |